Similar articles for PMID: 35105681

Year	Number of Results
2003	1
2004	2
2005	1
2006	1
2007	2
2009	1
2011	2
2012	2
2013	5
2014	7
2015	8
2016	10
2017	9
2018	12
2019	13
2020	12
2021	13
2022	6

1

A human factors approach to quality improvement in oxygen prescribing.

Watson A, Rahul M, Dominic F, Higgs J, Williamson A, Turner A. Watson A, et al. Clin Med (Lond). 2022 Mar;22(2):153-159. doi: 10.7861/clinmed.2021-0164. Epub 2022 Feb 1. Clin Med (Lond). 2022. PMID: 35105681 Free PMC article.

2

Medication prescribing for asthma and COPD: a register-based cross-sectional study in Swedish primary care.

Weidinger P, Nilsson JL, Lindblad U. Weidinger P, et al. BMC Fam Pract. 2014 Mar 25;15:54. doi: 10.1186/1471-2296-15-54. BMC Fam Pract. 2014. PMID: 24666507 Free PMC article.

3

Time for change in practice of in-patient oxygen therapy: a period-limited, multidimensional approach to improve oxygen prescription compliance: quality improvement project at Hamad General Hospital, Qatar.

Rose S, Sardar S, Sasi S, Al Mohanadi DHSH, Al-Mohammed AAAA, Zahid M. Rose S, et al. BMJ Open Qual. 2021 Nov;10(4):e001574. doi: 10.1136/bmjoq-2021-001574. BMJ Open Qual. 2021. PMID: 34815252 Free PMC article.

4

Supported self-management for patients with moderate to severe chronic obstructive pulmonary disease (COPD): an evidence synthesis and economic analysis.

Jordan RE, Majothi S, Heneghan NR, Blissett DB, Riley RD, Sitch AJ, Price MJ, Bates EJ, Turner AM, Bayliss S, Moore D, Singh S, Adab P, Fitzmaurice DA, Jowett S, Jolly K. Jordan RE, et al. Health Technol Assess. 2015 May;19(36):1-516. doi: 10.3310/hta19360. Health Technol Assess. 2015. PMID: 25980984 Free PMC article. Review.

5

Does Cardiovascular Comorbidity Influence the Prescribing of Bronchodilators in Chronic Obstructive Pulmonary Disease?

Adesanoye DT, Willey CJ. Adesanoye DT, et al. Ann Pharmacother. 2017 Oct;51(10):855-861. doi: 10.1177/1060028017712531. Epub 2017 Jun 2. Ann Pharmacother. 2017. PMID: 28573879

6

Reassessment of Home Oxygen Prescription after Hospitalization for Chronic Obstructive Pulmonary Disease. A Potential Target for Deimplementation.

Spece LJ, Epler EM, Duan K, Donovan LM, Griffith MF, LaBedz S, Thakur N, Wiener RS, Krishnan JA, Au DH, Feemster LC. Spece LJ, et al. Ann Am Thorac Soc. 2021 Mar;18(3):426-432. doi: 10.1513/AnnalsATS.202004-364OC. Ann Am Thorac Soc. 2021. PMID: 33075243 Free PMC article.

7

Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD).

Janjua S, Pike KC, Carr R, Coles A, Fortescue R, Batavia M. Janjua S, et al. Cochrane Database Syst Rev. 2021 Sep 8;9(9):CD013381. doi: 10.1002/14651858.CD013381.pub2. Cochrane Database Syst Rev. 2021. PMID: 34496032 Review.

8

Determinants of initial inhaled corticosteroid use in patients with GOLD A/B COPD: a retrospective study of UK general practice.

Chalmers JD, Tebboth A, Gayle A, Ternouth A, Ramscar N. Chalmers JD, et al. NPJ Prim Care Respir Med. 2017 Jun 29;27(1):43. doi: 10.1038/s41533-017-0040-z. NPJ Prim Care Respir Med. 2017. PMID: 28663549 Free PMC article.

9

Predictors of treatment with antibiotics and systemic corticosteroids for acute exacerbations of asthma and chronic obstructive pulmonary disease in primary care.

Salwan AA, Spigt M, Laue J, Melbye H. Salwan AA, et al. BMC Fam Pract. 2015 Mar 24;16:40. doi: 10.1186/s12875-015-0256-3. BMC Fam Pract. 2015. PMID: 25887285 Free PMC article.

10

Influence of government-driven quality assessment program on patients with chronic obstructive pulmonary disease.

Park HJ, Kim SR, Kim S, Lee HS, Kim BY, Kim HK, Ahn SI, Shin JH, Lee JH, Park JW. Park HJ, et al. Respir Res. 2021 Mar 21;22(1):87. doi: 10.1186/s12931-021-01684-1. Respir Res. 2021. PMID: 33743704 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed